Poland· PL-100489031

Bucidar

A bupropion product containing bupropioni hydrochloridum, registered in Poland by Ranbaxy (Poland) Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC N06AX12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBucidarATCN06AX12REGISTER NO.PL-100489031PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Bupropion is registered in 13 of 19 countries.

Countries holding a registration under ATC N06AX12 (bupropion), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Bupropion · ATC N06AX12

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bupropion costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.10 in United States to $1.25 in Switzerland — a ×12 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Bupropion · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.25
  • IT Italy$0.90
  • US United States$0.10 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Bupropioni hydrochloridum
Manufacturer
Ranbaxy (Poland) Sp. z o.o.
Country
Poland (PL)
ATC code
N06AX12
ATC class
Bupropion
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991564070
  • gtin
    05909991564063

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

808 interactions on record for bupropion.

Graded by severity as the source publishes them — 230 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bupropion · interactions on record

808 records

  • 230 severe
  • 217 moderate
  • 4 minor
  • 316 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bupropion in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bupropion products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Bupropion !$tada, Bupropion +pharma
  • Belgium · Bupropion Eg, Bupropion Sandoz
  • Cyprus · Wellbutrin Xr
  • Czechia · Bupropion +pharma, Bupropion Neuraxpharm
  • Germany · Bupropion, Bupropion 1 A Pharma
  • Denmark · Bupropion Hydrochloride Zentiva, Bupropionhydrochlorid Stada
  • Estonia · Elontril
  • Spain · Bupropion Accord, Bupropión Cinfa
  • Finland · Bupropion Accord, Bupropion Omet Pharma
  • France · Zyban L.P.
  • United Kingdom (Northern Ireland) · Zyban
  • Greece · Wellbutrin Xr
  • Croatia · Bupropion Genericon, Wellbutrin Xr
  • Hungary · Elontril
  • Ireland · Zyban
  • Iceland · Bupropion Teva, Wellbutrin Retard
  • Italy · Bupropion Sun, Bupropione Doc
  • Lithuania · Elontril
  • Luxembourg · Bupropion Eg, Bupropion Ratiopharm
  • Latvia · Wellbutrin Sr
  • Malta · Bupropion Generis, Wellbutrin Xr
  • Netherlands · Bupropion Hcl 1a Retard 1a Pharma, Bupropion Hcl Accord
  • Norway · Bupropion Hydrochloride Teva, Bupropion Hydrochloride Zentiva
  • Portugal · Bupropiom Generis, Bupropiom Ratiopharm
  • Romania · Axabal, Elontril
  • Sweden · Bupropion Accord, Bupropion Bluefish
  • Slovenia · Bupropion Accord, Wellbutrin Xr
  • Slovakia · Bupropion Neuraxpharm, Elontril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6a8dc4bc-f42e-436c-ba86-b5649e4e1263
GET /v1/drugs/6a8dc4bc-f42e-436c-ba86-b5649e4e1263?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o zmodyfikowanym uwalnianiu",
  "source": "urpl",
  "strength": "150 mg",
  "packaging": "05909991564070 ¦ Rp ¦ 160161\n90 tabl.\n05909991564063 ¦ Rp ¦ 160162\n30 tabl.",
  "substance": "Bupropioni hydrochloridum 150 mg",
  "common_name": "Bupropioni hydrochloridum",
  "pl_product_id": "100489031",
  "pozwolenie_nr": "28835",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-01-24"
}

See everything about bupropion.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.